Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells

Anticancer Research

Volumn 25, Issue 1 A, 2005, Pages 397-402

  Waleh, Nahid S ^a   Chao, Wan Ru ^a   Bensari, Ahlem ^a   Zaveri, Nurulain T ^a  

^a SRI INTERNATIONAL   (United States)

Author keywords

Chemoprevention; EGCG analog; Epigallocatechin 3 gallate; Green tea; VEGF

Indexed keywords

EPIGALLOCATECHIN GALLATE; MESSENGER RNA; SR 13193; SR 13196; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TEA; TUMOR GROWTH;

BREAST NEOPLASMS; CATECHIN; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 16344394754     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Chung FL, Schwartz J, Herzog CR and Yang YM: Tea and cancer prevention: studies in animals and humans. J Nutr 133: 3268S-3274S, 2003.
2. Liao S, Umekita Y, Guo J, Kokontis JM and Hipakka RA: Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett 96: 239-243, 1995.
3. Lu YP, Lou YR, Xie JG, Peng QY, Liao J, Yang CS, Huang MT and Conney AH: Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA 99: 12455-12460, 2002.
4. Lambert JD and Yang CS: Mechanisms of cancer prevention by tea constituents. J Nutr 133: 3262S-3267S, 2003.
5. Muto S, Fujita K, Yamazaki Y and Kamataki T: Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 479: 197-206, 2001.
6. Yang GY, Liao J, Kim K, Yurkow EJ and Yang CS: Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19: 611-616, 1998.
7. Gupta S, Ahmad N, Nieminen AL and Mukhtar H: Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 164: 82-90, 2000.
8. Cao Y and Cao R: Angiogenesis inhibited by drinking tea. Nature 598: 381, 1999.
9. Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R and Albini A: Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 91: 822-832, 1999.
10. Salah N, Miller NJ, Papanga G, Tijburg L, Bolwell GP and Rice-Evans CA: Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322: 339-346, 1995.
11. Rice-Evans C: Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. Proc Soc Exp Biol Med 220: 262-266, 1999.
12. Chen C, Yu R, Owuor ED and Kong AN: Activation of antioxidant-response element (ARE), mitogen-activated protein kinase (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 23: 605-612, 2000.
13. 2 production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 21: 2035-2039, 2000,
14. Saeki K, Kobayashi N, Inazawa Y, Zhang H, Nishitoh H, Ichijo H, Isemura M and Yuo A: Oxidation-triggered c-jun N-terminal kinase (JNK) and p38 mitogen-activated (MAP) kinase pathways for apoptosis in human leukemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Biochem J 368: 705-720, 2002.
15. Nam S, Smith DM and Dou QP: Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 276: 13322-13330, 2001.
16. Leone M, Zhai D, Sareth S, Kitada S, Reed JC and Pellecchia M: Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res 63: 8118-8121, 2003.
17. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W and Yang CS: Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63: 7563-7570, 2003.
18. Tachibana H, Koga K, Fujimura Y and Yamada K: A receptor for green tea polyphenol EGCG. Nature Struct Mol Biol 11: 380-381, 2004.
19. Zaveri NT: Synthesis of a 3,4,5-trimethoxybenzoyl ester analogue of epigallocatechin-3-gallate (EGCG): a potential route to the natural product green tea catechin, EGCG. Org Lett 3: 843-846, 2001.
20. Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, Ellis L, Liu W, Go VL and Brooks MN: Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr 132: 2307-2311, 2002.
21. Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW and Weinstein IB: Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2: 350-359, 2002.
22. Jung YD, Kim MS, Shin BA, Chay KO, Ahn BW, Liu W, Bucana CD, Gallick GE and Ellis LM: EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 84: 844-850, 2001.
23. Waleh NS, Calaoagan J, Murphy J, Knapp AM, Sutherland RM and Laderoute KR: The redox-sensitive human antioxidant responsive element induces gene expression under low oxygen conditions. Carcinogenesis 19: 1333-1337, 1998.
24. Jung YD, Nakano K, Liu W, Gallick GE and Ellis LM: Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells. Cancer Res 59: 4804-4807, 1999.
25. Berra E, Pages G and Pouyssegur J: MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev 19: 138-145, 2000.
26. Guo Q, Zhao B, Shen S, Hou J, Hu J and Xin W: ESR study on the structure-antioxidant relationship of tea catechins and their epimers. Biochim Biophys Acta 1427: 13-23, 1999.
27. Valcic S, Muders A, Jacobsen NE, Liebler DC and Timmermann BN: Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin gallate with peroxyl radicals. Chem Res Toxicol 12: 382-386, 1999.
28. Tosetti P, Ferrari N, De Flora S and Albini A: Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J 16: 2-14, 2002.